Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
Main Authors: | Pooja Virmani, MBBS, Klaus Busam, MD, Patricia L. Myskowski, MD, Amy Yang, MD, Cynthia Magro, MD, Steven Horwitz, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617300644 |
Similar Items
-
CD20+ cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literature
by: Amanda J. Tschetter, MD, et al.
Published: (2020-04-01) -
Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma
by: Stefanie Porkert, et al.
Published: (2021-02-01) -
Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy
by: Blake W. Boudreaux, MD, et al.
Published: (2021-09-01) -
Intralesional Corticosteroids for Long-term Control of Primary Cutaneous Marginal Zone Lymphoma without systemic involvement
by: Pragya Tiwari, et al.
Published: (2019-07-01) -
Primary cutaneous marginal zone lymphoma (immunocytoma like) with lymphoepithelioid or Lennert′s lymphoma like involvement of nodes
by: Tanuja Shet, et al.
Published: (2012-01-01)